ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print February 6, 2008, 10.1183/09031936.00121406
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Hung, C-H.
Right arrow Articles by Jong, Y-J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hung, C-H.
Right arrow Articles by Jong, Y-J.
Eur Respir J 2008; 31:1313-1321
Copyright ©ERS Journals Ltd 2008

Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells

C-H. Hung1,2,3, Y-T. Chu2, Y-M. Hua4, S-H. Hsu3, C-S. Lin3, H-C. Chang3, M-S. Lee2 and Y-J. Jong1,2,3

1 Dept of Paediatrics, Faculty of Paediatrics, College of Medicine, 2 Dept of Paediatrics, Kaohsiung Medical University Hospital, and 3 Graduate Institute of Medicine, Kaohsiung Medical University, and 4 Dept of Paediatrics, Tri-Service General Hospital, Kaohsiung, Taiwan, Republic of China.

CORRESPONDENCE: Y-J. Jong, Dept of Paediatrics, Kaohsiung Medical University Hospital, No. 100, Tz-You 1st Road, Kaohsiung 807, Taiwan, Republic of China. Fax: 886 73213931. E-mail: pedhung{at}kmu.edu.tw

Keywords: β2-Adrenoreceptor agonist, bronchial epithelial cells, bronchodilators, CC chemokines, macrophage, monocyte

Received: September 15, 2006
Accepted January 27, 2008

It is unknown whether formoterol and salmeterol, two long-acting β2-adrenoreceptor agonists, have regulatory functions in the production of T-helper cell (Th) type 2- and Th1-related chemokines by monocytes and bronchial epithelial cells.

In the present study, the effects of formoterol and salmeterol on lipopolysaccharide (LPS)-induced expression of the Th2-related chemokine macrophage-derived chemokine (MDC; CCL22) and the Th1-related chemokine interferon-{gamma}-inducible protein (IP)-10 (CXCL10) were investigated in a monocytic cell line, THP-1, and in human primary monocytes. In addition, their effects on the expression of the Th2-related chemokine thymus- and activation-regulated chemokine (TARC; CCL17) were evaluated in an epithelial cell line, BEAS-2B.

Formoterol enhanced MDC but suppressed IP-10 production in monocytes induced by LPS. Higher doses of salmeterol were required to enhance LPS-induced MDC expression in THP-1 cells. Formoterol and salmeterol could significantly suppress TARC expression in BEAS-2B cells. These effects could be reversed by a selective β2-adrenoreceptor antagonist, ICI-118551. Formoterol- and LPS-induced MDC expression was inhibited by budesonide.

Both long-acting β2-adrenoreceptor agonists suppressed thymus- and activation-regulated chemokine expression in bronchial epithelial cells mediated via β2-adrenoreceptors. Formoterol at physiological concentrations could suppress lipopolysaccharide-induced T-helper cell type 1-related chemokine (interferon-{gamma}-inducible protein-10) but enhance T-helper cell type 2-related chemokine (macrophage-derived chemokine) expression in human monocytes. Long-acting β2-adrenoreceptor agonists may increase T-helper cell type 2-related chemokine expression in monocytes and T-helper cell type 2 recruitment and, therefore, long-acting β2-adrenoreceptor agonist monotherapy may not be an appropriate therapeutic option for asthma.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.